ZP
EOLS icon

Zimmer Partners’s Evolus EOLS Stock Holding History

Zimmer Partners’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-330,000
Closed -$2.03M – 138
2025
Q3 		$2.03M Sell
330,000
-300,000
-48% -$2.34M 0.04% 125
2025
Q2 		$5.8M Buy
630,000
+125,000
+25% +$1.28M 0.13% 107
2025
Q1 		$6.08M Buy
505,000
+88,500
+21% +$1.16M 0.11% 109
2024
Q4 		$4.6M Buy
416,500
+166,500
+67% +$2.34M 0.08% 108
2024
Q3 		$4.05M Sell
250,000
-251,629
-50% -$3.52M 0.07% 113
2024
Q2 		$5.44M Buy
501,629
+201,629
+67% +$2.48M 0.1% 105
2024
Q1 		$4.2M Buy
+300,000
New +$3.9M 0.09% 99

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zimmer Partners's EOLS Position: Q4 2025 in Review

Zimmer Partners sold out of Evolus (EOLS) in Q4 2025, closing a stake of 330,000 shares — an estimated $2.03M sold.

Zimmer Partners first reported a position in EOLS in Q1 2024 and held it in 7 quarters. The position peaked at $6.08M in Q1 2025. 169 funds tracked by Wall St. Rank hold EOLS as of Q4 2025.

  • Zimmer Partners reported no remaining Evolus position as of Q4 2025 after selling out during the quarter.
  • Zimmer Partners sold 330,000 Evolus shares in Q4 2025, an estimated $2.03M.
  • Zimmer Partners first reported a position in Evolus in Q1 2024 and held it in 7 quarters.
  • Zimmer Partners's Evolus position peaked at $6.08M in Q1 2025.
  • 169 funds tracked by Wall St. Rank held Evolus as of Q4 2025.

Based on Zimmer Partners's 13F filing for Q4 2025, filed 17 Feb 2026.